Dr. Cornelius Taabazuing earned his B.S in Biochemistry and Molecular Biology and his Ph.D. in Biological Chemistry from the University of Massachusetts Amherst. He then joined the Department of Chemical Biology at Memorial Sloan-Kettering Cancer Center for his postdoctoral studies. Currently, he is a Presidential Assistant Professor in the Department of Biochemistry and Biophysics at the University of Pennsylvania. The focus of his lab is to uncover the molecular mechanisms of cell death pathways, specifically, apoptosis and pyroptosis. Dr. Taabazuing has won numerous awards, including the Tri-Institutional Breakout Prize for Young Investigators, the NIH K99/R00 Pathway to Independence Award, and the Vanderbilt University Juneteenth New Investigator Award for 2022. Dr. Taabazuing is passionate about increasing diversity and equity in the life sciences and has been a champion for institutional policy changes that improve DEI in STEM.
Dr. Cornelius Taabazuing earned his B.S in Biochemistry and Molecular Biology and his Ph.D. in Biological Chemistry from the University of Massachusetts Amherst. He then joined the Department of Chemical Biology at Memorial Sloan-Kettering Cancer Center for his postdoctoral studies. Currently, he is a Presidential Assistant Professor in the Department of Biochemistry and Biophysics at the University of Pennsylvania. The focus of his lab is to uncover the molecular mechanisms of cell death pathways, specifically, apoptosis and pyroptosis. Dr. Taabazuing has won numerous awards, including the Tri-Institutional Breakout Prize for Young Investigators, the NIH K99/R00 Pathway to Independence Award, and the Vanderbilt University Juneteenth New Investigator Award for 2022. Dr. Taabazuing is passionate about increasing diversity and equity in the life sciences and has been a champion for institutional policy changes that improve DEI in STEM.